​​Monkeypox: Member coverage for laboratory testing, vaccination, and treatment​

September 13, 2022

​Effective for dates of service on or after May 17, 2022, Independence Blue Cross and Independence Administrators have communicated their coverage positions on laboratory testing, vaccination, and treatment for Monkeypox for Commercial and Medicare Advantage members.

To read the full coverage statements, view the following news articles that were published on August 24, 2022:

For important updates regarding Monkeypox, visit the Commercial and Medicare Advantage News & Announcements sections of the Medical and Claim Payment Policy Portal.